NSE: TTKHLTCARE | BSE: 507747

Falling Comet

Download real time

1205.60 6.20 (0.52%)

36.34% Fall from 52W High

4,180 NSE+BSE Volume

NSE 16 May, 2025 3:31 PM (IST)

1,703.5

Market Cap

Below industry Median

0.7

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for TTK Healthcare Ltd. is on 23 May 2025 for the purpose of Audited Results & Final Dividend See details

TTK Healthcare Ltd. share price target and research reports

Name: Latest research reports of TTK Healthcare Ltd. authored by Rudra Shares and Stock Brokers Ltd and published by - Trendlyne research reports.
Item: TTK Healthcare Ltd.
Rating: 5
Author: Rudra Shares and Stock Brokers Ltd

Latest analyst research reports with target prices and PDF download for TTKHLTCARE, BSE:507747 TTK Healthcare Ltd.

Search Inside the pdf :

TTK Healthcare Ltd.

17 May 2018, 12:00AM

1205.60

0.52%

TTK Healthcare Ltd

Buy: TTK Healthcare Ltd.

Rudra Shares and Stock Brokers Ltd

TTK Healthcare is the first pharmaceutical company in India to market life-saving products based on technology, like Urokinase and Dopamine and has a strong sales and distribution force throughout the country and also have export potential. Company Exports to UK, Egypt, USA, Singapore, Germany, Malaysia, and Caribbean countries. Company has alliances with foreign corporations including Kali-Chemi and London International (Germany), Hatu-ICO (Spain),...

TTK Healthcare Ltd. is trading above its 50 day SMA of 1193.5

Is TTK Healthcare Ltd. worth buying?

48 Votes:

Buy 72.92%

Sell 10.42%

Hold 16.67%